SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report)'s stock price traded down 3.6% during trading on Friday . The stock traded as low as $4.75 and last traded at $4.93. 39,533 shares traded hands during trading, a decline of 35% from the average session volume of 60,894 shares. The stock had previously closed at $5.11.
SBC Medical Group Stock Performance
The stock's fifty day moving average is $3.79 and its two-hundred day moving average is $4.64. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.76 and a current ratio of 2.79.
SBC Medical Group (NASDAQ:SBC - Get Free Report) last posted its quarterly earnings data on Thursday, May 15th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.11 by $0.10. The firm had revenue of $47.33 million during the quarter, compared to analysts' expectations of $51.52 million. Research analysts expect that SBC Medical Group Holdings Incorporated will post 5.02 EPS for the current year.
About SBC Medical Group
(
Get Free Report)
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.
Featured Stories
Before you consider SBC Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.
While SBC Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
